Signal active
Organization
Contact Information
Overview
Inherent Biosciences is a molecular diagnostics company that revolutionizes trial and error medicine and restore hope. The company does this by discovering what's inherent in our biology about the unexplained and translating discoveries into personal insights that inform actions.
Inherent Biosciences develops medicines for treating pain, infertility, embryo quality, autism, rheumatoid arthritis, psoriatic arthritis, fetal heart disease, COVID-19, and many more.
About
Biotechnology, Health Care, Therapeutics
2019
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Inherent Biosciences headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $129.4M in funding across 60 round(s). With a team of 1-10 employees, Inherent Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Inherent Biosciences, raised $1.9M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
5
1
0
$2.2M
Details
2
Inherent Biosciences has raised a total of $2.2M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed | |||
2022 | Early Stage Venture |
Investors
Inherent Biosciences is funded by 20 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Inherent Biosciences | - | FUNDING ROUND - Inherent Biosciences | undefined |
Portfolia | - | FUNDING ROUND - Portfolia | undefined |
Inherent Biosciences | - | FUNDING ROUND - Inherent Biosciences | 1.9M |
National Institutes of Health | - | FUNDING ROUND - National Institutes of Health | 1.9M |
Recent Activity
There is no recent news or activity for this profile.